Global Lead, RSV Adult Vaccine Evidence Strategy

A leading global pharmaceutical company seeks a qualified candidate to oversee the medical evidence strategy for its RSV adult vaccine program. The role includes designing epidemiological studies, ensuring study execution harmonization, and coordinating evidence generation work. Ideal candidates will have a PhD, over 10 years in vaccine activities, and expertise in adults' RSV epidemiology. This hybrid role requires living within commuting distance to the Phoenix office, with a competitive salary range from $230,900 to $384,800, plus bonuses and benefits. #J-18808-Ljbffr